Accuray Incorporated  

(Public, NASDAQ:ARAY)   Watch this stock  
Find more results for ARAY
7.87
-0.36 (-4.37%)
Jul 31 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 7.85 - 8.16
52 week 5.64 - 10.85
Open 8.16
Vol / Avg. 0.00/649,224.00
Mkt cap 604.14M
P/E     -
Div/yield     -
EPS -0.59
Shares 76.76M
Beta 0.75
Inst. own 107%
Aug 21, 2014
Q4 2014 Accuray Incorporated Earnings Release - 4:00PM EDT - Add to calendar
Jun 12, 2014
Accuray Incorporated at Goldman Sachs Healthcare Conference - Webcast
Jun 3, 2014
Accuray Incorporated at Jefferies Global Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin -4.80% -30.81%
Operating margin -0.49% -25.53%
EBITD margin - -14.56%
Return on average assets -3.83% -20.52%
Return on average equity -19.59% -64.38%
Employees 232 -
CDP Score - -

Address

1310 Chesapeake Terrace
SUNNYVALE, CA 94089
United States - Map
+1-408-7164600 (Phone)
+1-408-7164601 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Accuray, Inc. manufactures image-guided radiosurgery devices. The Company is based in the United States and its core product, the CyberKnife Stereotactic Radiosurgery System, combines image-guidance with robotics to offer unparalleled flexibility and accuracy. Accuray's focus is to revolutionize the treatment of solid cancers throughout the body by the precise delivery of high doses of radiation using the CyberKnife Stereotactic Radiosurgery System.

Officers and directors

Louis J. Lavigne Jr. Independent Chairperson of the Board
Age: 65
Bio & Compensation  - Reuters
Joshua H. Levine President, Chief Executive Officer, Director
Age: 55
Bio & Compensation  - Reuters
Elizabeth H. Davila Independent Vice Chairperson of the Board
Age: 69
Bio & Compensation  - Reuters
Gregory E. Lichtwardt Chief Financial Officer, Executive Vice President
Age: 59
Bio & Compensation  - Reuters
Kelly Londy Executive Vice President, Chief Commercial Officer
Age: 46
Bio & Compensation  - Reuters
Alaleh Nouri Interim General Counsel and Corporate Secretary
Bio & Compensation  - Reuters
Jack Goldstein Ph.D. Independent Director
Age: 66
Bio & Compensation  - Reuters
Richard R. Pettingill Independent Director
Age: 65
Bio & Compensation  - Reuters
Emad Rizk Independent Director
Age: 50
Bio & Compensation  - Reuters
Robert S. Weiss Independent Director
Age: 66
Bio & Compensation  - Reuters